Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239
9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene
Carbonara C, Longa L, Grosso E, et al (1994) 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3:1829-1832
Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
Green AJ, Smith M, Yates JRW (1994a) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet 6:193-196
Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease
Kandt RS, Haines JL, Smith M, et al (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nature Genet 2:37-41
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild type chromosome
Smith SA, Easton DF, Evans DRG, Ponder BAJ (1991) Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild type chromosome. Nature Genet 2:128-131
Identification and characterisation of the tuberous sclerosis gene on chromosome 16
The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterisation of the tuberous sclerosis gene on chromosome 16. Cell 75:1-11